ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Ascendis Pharma A/S (ASND) shows an Average True Range (ATR) of 6.1 and an Enterprise Value of 7.82B. Its average trading volume over the past 3 months is 455.15K, indicating liquidity. These fundamental metrics provide insight into ASND's underlying financial health and market activity.
Ascendis Pharma A/S (ASND) technical indicators as of October 2, 2025: the SMA 20 is 1.62%, SMA 50 at 4.94%, and SMA 200 at 23.07%. The RSI 14 value is 57.45, suggesting its current momentum. These technical analysis signals help assess ASND's price trends and potential future movements.
Ascendis Pharma A/S (ASND) stock performance overview as of October 2, 2025: The 52-week high is $208.16 (currently -3.45% below), and the 52-week low is $118.03 (currently 70.27% above). Over the past year, ASND's performance is 38.96%, compared to the S&P 500's 15.68% change.
According to market data, Ascendis Pharma A/S (ASND) stock's recent performance metrics show that over the last month, ASND is 0.47%, with a Year-to-Date (YTD) performance of 45.98%. Over the past year, the stock has seen a 38.96% change. These figures summarize ASND's price movements across various periods, reflecting its historical returns.
According to current financial data, ASND stock's P/E (TTM) ratio is -38.20, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ASND, including P/S (21.14), P/B (-55.22), and P/FCF (-60.71), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.